NHS home testing identifies hundreds with hepatitis C More than 105,000 people in England have ordered the test since the home-testing service launched in May 2023, with more than 200 testing positive.…
Genomics surveillance programme for hepatitis C launched by UK Health Security Agency In order to monitor hepatitis C virus strains that are resistant to antiviral medicines, the UK Health Security Agency has set up a genomic surveillance programme to seek genetic markers for drug resistance.…
Hepatitis C ‘micro-eliminated’ at UK’s largest prison The test-and-treat programme is part of a plan from Welsh government to micro-eliminate hepatitis C in the community and in all Welsh prisons.…
How we treated more than 100 hepatitis C patients at pharmacist-led clinics in North Wales Prescribing pharmacist Elizabeth Hurry explains how her team developed an accelerated care pathway to test and treat “hard to reach” patients with hepatitis C.…
Community pharmacies have an essential role in sustaining the elimination of hepatitis C in England Pharmacies can provide easy access to hepatitis C testing for people who inject drugs, helping to control infection rates and allow the elimination of the virus in England by 2025.…
Advanced service to pay pharmacies £36 per point-of-care hepatitis C test delivered Contractors in England will be reimbursed £36 for each point-of-care hepatitis C test offered as part of an advanced service, which will launch on 1 September 2020.…
Case-finding intervention helps GPs identify and treat patients with hepatitis C An intervention designed to help GP practices identify and refer patients for hepatitis C testing and treatment is both effective and cost-effective, research published in the BMJ has found.…
Greggs vouchers offered to encourage drug users to get tested for hepatitis C Substance misuse and needle exchange patients in Newcastle will be given “up to £25 of Greggs vouchers” if they present for a blood spot test for hepatitis C in a community pharmacy.…
Hepatitis C testing for people with any risk factor more cost effective Testing individuals with any risk factor for the hepatitis C virus is more cost effective than restricting screening to people with a history of injecting drugs, a study based in the Isle of Wight has found.…
New clinical roles in cardiovascular disease and hepatitis C in community pharmacy contract Community pharmacists could be involved in detecting undiagnosed cardiovascular disease under plans laid out in the ‘The Community Pharmacy Contract Framework for 2019/20 to 2023/24’.…
